Nomogram predicting leukopenia in osteosarcoma after high-dose methotrexate chemotherapy

HIGHLIGHTS

  • who: Haixiao Wu and collaborators from the Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin`s Clinical Research Center for Cancer, Tianjin, China have published the research work: Nomogram predicting leukopenia in osteosarcoma after high-dose methotrexate chemotherapy, in the Journal: (JOURNAL)
  • what: The analysis in this study showed that the incidence of severe delayed MTX excretion was significantly higher in female OS patients than in male OS patients . This study investigated the risk of LP in OS patients during the MTX . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?